Technology. It influences every aspect of our lives and plays a part in everything we do. Remarkable advancements have been made in so many areas of technology in the last 10 years – in travel, in Information Technology, and even in the way we do our weekly grocery shopping – but what about in healthcare?
Clinical diagnostics, or the analysis of a patient’s blood in a medical laboratory, affects over 70% of medical decisions made, and yet it still only accounts for about 2% of our healthcare budget. With such disparity between the importance of diagnostics and the lack of investment made in this field of medicine, it is imperative that we utilise technology to improve the speed and accuracy of health diagnoses across the world.
Enter Randox. For over 35 years the diagnostics company has been quietly and humbly carrying out ground-breaking research and development in blood science technology, transforming the way patients are diagnosed and treated in over 145 countries. But it exploded on to the public stage in 2017, when it took on the sponsorship of the world’s greatest steeplechase, the Randox Health Grand National. After all, with technology this ground-breaking, world-changing and most importantly, life-extending, wouldn’t you want to tell the world?
Randox Health, founded by a man with a vision, growing from a small laboratory to a global diagnostic leader in the space of just 36 years, is not afraid to be disruptive to in its quest to bring pioneering biotechnology to patients around the globe. “We believe we have entered an era of enlightenment,” says Managing Director Dr Peter FitzGerald.
“Rather than waiting to get sick, people want to take their health into their own hands – and innovative diagnostics are the key in unlocking the potential to do this. We’ve invested over £285 million into the development of the gold standard in medical testing – and already it has revolutionised the diagnostics industry.”
He is of course referring to the company’s patented Biochip Array Technology – a unique testing platform which can measure hundreds of biomarkers within your blood simultaneously, across a wide variety of areas including cardiac, thyroid, bone, diabetes and kidney health.
The unique approach taken by this state-of-the-art technology moves beyond the isolated testing taking place in the current clinical environment - which often provides a patchy representation of your health. In the GP setting for example, an average of 3-5 tests will be run. In contrast, Randox Health conducts up to 350 test results and analyses them collectively to understand what’s going on in the body as a whole.
Thanks to an investment of around 16% of the company’s annual turnover into research and development, Randox scientists work on pioneering research in a range of common illnesses such as cancer, cardiovascular disease and Alzheimer’s disease. New tests are therefore added to the Randox Health menu every year, making it the world’s most comprehensive health check - which stays up-to-date as new medical advances are discovered. Standard tests for the likes of cholesterol and red blood cell count are carried out at the same time as pioneering and exclusive tests for genetic diseases you may not even have heard of.
By simultaneously analysing this vast array of health indicators within the body, Randox Health provides a full profile of your current health status and impressively, a roadmap of your future health – enabling you to spot illnesses early, take prevention action, and fundamentally, extend your life.
Randox Health’s revolutionary health programmes are available in its clinics located in Belfast, London, and now Liverpool.
For those interested in availing of the company’s pioneering Biochip Array Technology, to extend and improve your life, you can contact the team on 0800 2545 130 or visit